Author

Xavier Golay

Primary ORCID profile (0000-0002-6447-4446 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Xavier GolayiD2 papers · National Hospital for Neurology and Neurosurgery

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:imaging· 1 Approach:microscopy & imaging analysis· 1 Organism:mouse· 1

Frequent Co-Authors

Alasdair Gibb· 1 shared Daniel Bradley· 1 shared Mark F Lythgoe· 1 shared Nibedita Chattopadhyay· 1 shared R Barbara Pedley· 1 shared Rajiv Ramasawmy· 1 shared Sean Peter Johnson· 1 shared Simon Walker-SamueliD· 1 shared

Activity by Year

2017-2017 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiophysics

Alasdair Gibb

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Development of noninvasive biomarkers of response to proteasome inhibitor therapy (ixazomib) by imaging disrupted protein homeostasis in mouse models of solid tumors

Yanan Zhu, Rajiv Ramasawmy, Sean Peter Johnson, Valerie Taylor, Alasdair Gibb, R Barbara Pedley, Nibedita Chattopadhyay, Mark F Lythgoe, Xavier Golay, Daniel Bradley, Simon Walker-Samuel

This study uses CEST MRI to noninvasively monitor proteasome inhibitor response in mouse tumor models, showing increased CEST signals with higher drug doses and varying tumor sensitivity.

bioRxiv · Sep 25, 2017 · PreprintBiophysics